Hindustan Bio Sciences Financials

BSE: 532041

₹8.31

₹-0.40 (-4.59%)

As on 31-Aug-2026IST

Market cap

₹9 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

12

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	0.38	0.81	1.05	0.92	0.43	1.03
Total Income	0.41	0.81	1.05	0.92	0.43	1.03
Total Expenditure	0.60	0.71	0.99	0.95	0.94	1.97
EBITDA	-0.21	0.10	0.06	-0.03	-0.51	-0.94
Depreciation	0.02	0.00	0.01	0.01	0.00	0.01
EBIT	-0.23	0.10	0.06	-0.03	-0.51	-0.95
Interest	0.00	0.00	0.00	0.00	0.00	0.01
Other Income	0.03	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.21	0.10	0.05	-0.04	-0.51	-0.96
Provision for Tax	--	0.00	0.00	0.00	0.00	-0.02
Profit after Tax	-0.21	0.10	0.06	-0.04	-0.52	-0.94

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	0.83	0.90	0.80	0.75	0.79	1.30
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.35	2.50	2.55	1.12	1.07	0.72
Current Liabilities	0.02	0.01	0.01	1.42	1.12	1.45
Total Liabilities	3.20	3.42	3.37	3.29	2.98	3.49

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	0.02	2.42	2.42	2.42	2.43	2.43
Current Assets	0.77	1.00	0.95	0.86	0.54	1.05
Total Assets	3.20	3.42	3.37	3.29	2.98	3.49
Total Debt*	--	2.51	2.56	2.46	2.17	1.86
Net Current Assets	0.75	0.98	0.94	-0.56	-0.58	-0.40
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	0.03	-1.41	-0.05	-0.34	0.75
Cash Flow from Investing Activities	--	--	--	--	0.00	--
Cash from Financing Activities	--	-0.05	1.43	0.05	0.34	-0.93
Net Cash Inflow / Outflow	--	-0.02	0.03	0.00	-0.01	-0.18

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-0.20	0.10	0.06	-0.04	-0.50	-0.92
Cash EPS (₹)	-0.20	0.10	0.06	-0.03	-0.50	-0.91
Adjusted Book Value (₹)	0.69	0.88	0.78	0.73	0.77	1.27
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.03	-1.37	-0.05	-0.33	0.73
Free Cash Flow per Share (₹)	--	0.03	-1.37	-0.05	-0.56	0.70

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	2.94	1.74	-1.10	-16.66	-23.70
ROE (%)	-24.67	11.78	7.43	-5.28	-49.49	-52.96
ROA (%)	-6.28	2.97	1.73	-1.29	-16.05	-20.83
EBIT Margin (%)	-61.26	12.25	5.42	-3.67	-118.32	-91.91
Net Margin (%)	-50.86	12.38	5.47	-4.39	-120.19	-91.08
Cash Profit Margin (%)	0.00	12.41	6.12	-3.77	-119.40	-90.30

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-65.52	-22.75	14.15	114.19	-58.27	-46.90
EBIT Growth (%)	-290.24	74.43	268.68	93.36	46.28	-860.91
Net Profit Growth (%)	-229.19	74.83	242.39	92.18	44.93	-1,262.13
EPS Growth (%)	-229.15	74.73	242.28	92.18	44.93	-1,262.19
Book Value Growth (%)	--	12.52	7.72	-5.14	-39.67	-41.87

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-40.95	71.05	129.03	--	--	--
Price / Book Value	12.00	7.91	9.24	7.30	5.50	2.36
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-57.42	96.69	155.76	-280.16	-12.81	-5.23
Close Price (₹)	7.30	6.98	7.25	5.32	4.22	3.00
High Price (₹)	9.92	13.47	15.18	5.60	5.96	5.12
Low Price (₹)	5.00	6.70	5.15	3.23	2.62	1.00
Market Cap (₹ Cr)	8.52	7.16	7.43	5.45	4.33	3.08

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	2.85	2.77	3.18	3.29	2.75	1.42
Short term debt to equity ratio	--	--	--	1.79	1.39	0.86
Current Ratio	38.60	73.30	68.84	0.61	0.48	0.72
Quick Ratio	38.60	73.30	68.84	0.61	0.48	0.72
Interest Coverage	-207.00	71.14	15.03	-8.26	-102.33	-138.03

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	13.87	54.35	41.99	49.18	31.35	59.82
Asset Turnover	0.12	0.24	0.32	0.30	0.13	0.23
Receivable days	--	198.39	155.26	116.47	318.86	350.27
Inventory Days	--	--	--	--	--	--
Payable days	--	0.81	18.90	21.18	225.24	255.46
Cash Conversion Cycle	--	197.57	136.37	95.28	93.62	94.81

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.